Perspective Therapeutics (CATX) Cash from Investing Activities (2010 - 2026)

Perspective Therapeutics has reported Cash from Investing Activities for 17 years, with the latest figure at -$109.6 million in Q1 2026.

• Quarterly Cash from Investing Activities fell 1868.61% year-over-year to -$109.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$62.8 million (up 64.58% YoY) and the FY2025 annual result came in at $41.2 million, up 118.83% from the prior year.
• Cash from Investing Activities declined to -$109.6 million in Q1 2026 per CATX's latest filing, from $28.5 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $28.5 million in Q4 2025 and troughed at -$138.6 million in Q4 2024.
• A 5-year average of -$19.2 million and a median of -$573000.0 in 2023 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities surged 97261.54% in 2023, then slumped 155632.58% in 2024.
• Over 5 years, Cash from Investing Activities stood at -$28.8 million in 2022, then jumped by 99.69% to -$89000.0 in 2023, then plunged by 155632.58% to -$138.6 million in 2024, then surged by 120.59% to $28.5 million in 2025, then plunged by 483.9% to -$109.6 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$109.6 million, $28.5 million, and $14.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.